And not only intact, but strengthened and strengthened because of increased awareness of the importance of treating hearing loss. And despite all those things we had as we set out to do 2.5 years ago emerged from this period with a stronger organization with our long-term strategy intact. As always, our mission has been a wonderful guide for us over the history of Cochlear, but particularly over the last 2.5 years, where obviously we have seen waves of COVID come through the impact of COVID on hospitals, in terms of hospital waiting lists, restrictions on immigration, which caused shortage - staff shortages in hospitals restricting access to care, supply chain disruption, which we all have heard and seen and more recently inflation. We'll go straight in, as I said, and then we'll have questions at the end. Diggory William Howitt, Cochlear Limited - CEO, MD, President & Executive Director - Good morning, and thank you all for joining for our F '22 results presentation. (Operator Instructions) I would now like to hand the conference over to Dig Howitt, Chief Executive Officer and President.
Laaman Morgan Stanley, Research Division - Australian Healthcare Analyst * Steven David Wheen Jarden Limited, Research Division - Analyst = Presentation - Operator - Thank you for standing by, and welcome to the Cochlear Limited FY '22 Results Analyst and Media Briefing. Low JPMorgan Chase & Co, Research Division - Research Analyst * David Andrew Stanton Jefferies LLC, Research Division - Equity Analyst * Gretel Janu Crédit Suisse AG, Research Division - Research Analyst * Jackson Lee * John Deakin-Bell Citigroup Inc., Research Division - Director & Head of Healthcare in Australia & New Zealand * Lyanne Harrison BofA Securities, Research Division - VP in Global Equity Research * Saul Hadassin Barrenjoey Markets Pty Limited, Research Division - Analyst * Sean M. Ltd., Research Division - Director of Healthcare * David A.
KANSO 2 USER GUIDE FULL
Full Year 2022 Cochlear Ltd Earnings Call Sydney (Thomson StreetEvents) - Edited Transcript of Cochlear Ltd earnings conference call or presentation Friday, Augat 12:00:00am GMT TEXT version of Transcript = Corporate Participants = * Diggory William Howitt Cochlear Limited - CEO, MD, President & Executive Director * Stuart Sayers Cochlear Limited - CFO = Conference Call Participants = * Andrew Goodsall MST Marquee - Healthcare analyst * Chris Cooper Goldman Sachs Group, Inc., Research Division - Research Analyst * Craig Wong-Pan RBC Capital Markets, Research Division - Analyst * David Bailey Macquarie Research - Analyst * David Nayagam Evans & Partners Pty.
0 kommentar(er)
